Chiral Reagents
Items 251 to 260 of 465 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
R-Venlafaxine | 93413-46-8 | sc-208209 | 5 mg | $430.00 | ||
R-Venlafaxine serves as a chiral reagent characterized by its ability to engage in specific stereoselective interactions. Its unique conformation enables it to stabilize transition states, thereby influencing reaction pathways and enhancing enantioselectivity. The compound's distinct electronic properties facilitate selective binding with chiral catalysts, while its solvation behavior can modulate reaction kinetics, making it a versatile tool in asymmetric synthesis. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
Fluvastatin, as a chiral reagent, exhibits remarkable selectivity in asymmetric reactions due to its unique stereochemical configuration. Its rigid structure promotes specific molecular interactions, allowing for the stabilization of chiral intermediates. The compound's ability to form hydrogen bonds enhances its reactivity, while its distinct electronic characteristics influence the rate of enantioselective transformations. This makes it a valuable asset in the development of chiral compounds. | ||||||
(3R,5S)-Fluvastatin Sodium Salt | 94061-80-0 | sc-206732 | 1 mg | $360.00 | 1 | |
(3R,5S)-Fluvastatin Sodium Salt serves as an effective chiral reagent, characterized by its unique stereogenic centers that facilitate selective interactions in asymmetric synthesis. The compound's spatial arrangement allows for preferential binding to substrates, enhancing enantioselectivity. Its polar functional groups contribute to solubility and reactivity, while the presence of specific stereoelectronic effects can modulate reaction kinetics, making it a versatile tool in chiral synthesis. | ||||||
Cicaprost | 94079-80-8 | sc-358799 sc-358799A | 500 µg 1 mg | $638.00 $1230.00 | ||
Cicaprost is a chiral reagent distinguished by its unique structural features that promote specific molecular interactions in asymmetric synthesis. Its stereochemistry enables selective recognition of chiral substrates, enhancing enantioselectivity in reactions. The compound's functional groups influence its reactivity and solubility, while its ability to stabilize transition states can significantly affect reaction pathways and kinetics, making it a valuable asset in the realm of chiral chemistry. | ||||||
(R)-(+)-Carvedilol | 95093-99-5 | sc-212656A sc-212656 sc-212656B sc-212656C sc-212656D | 2 mg 5 mg 10 mg 25 mg 50 mg | $281.00 $322.00 $650.00 $1441.00 $2507.00 | 3 | |
(R)-(+)-Carvedilol serves as a chiral reagent characterized by its ability to facilitate enantioselective transformations through unique steric and electronic properties. Its distinct chiral center allows for preferential interactions with substrates, leading to enhanced selectivity in asymmetric reactions. The compound's diverse functional groups contribute to its reactivity profile, influencing both the stability of intermediates and the overall kinetics of the reaction, thereby optimizing synthetic pathways in chiral synthesis. | ||||||
(S)-(−)-Carvedilol | 95094-00-1 | sc-212831 | 5 mg | $360.00 | 3 | |
(S)-(-)-Carvedilol acts as a chiral reagent, exhibiting remarkable selectivity in asymmetric synthesis due to its specific stereochemistry. The compound's unique spatial arrangement enables it to engage in favorable non-covalent interactions with substrates, enhancing enantioselectivity. Its multifunctional nature allows for diverse reaction pathways, influencing the formation of chiral intermediates and optimizing reaction rates, making it a versatile tool in chiral chemistry. | ||||||
Difloxacin hydrochloride | 91296-86-5 | sc-205648 sc-205648A | 5 g 25 g | $194.00 $863.00 | ||
Difloxacin hydrochloride serves as a chiral reagent, characterized by its ability to facilitate enantioselective transformations through specific steric and electronic interactions. Its unique molecular architecture promotes selective binding to chiral substrates, leading to distinct reaction pathways. The compound's dynamic behavior in solution enhances reaction kinetics, allowing for efficient formation of chiral products while minimizing racemic byproducts, thus proving advantageous in asymmetric synthesis. | ||||||
(+)-N-Benzyl-(3R,4R)-bis(diphenylphosphino)pyrrolidine | 99135-95-2 | sc-228665 | 100 mg | $132.00 | ||
(+)-N-Benzyl-(3R,4R)-bis(diphenylphosphino)pyrrolidine acts as a chiral reagent, distinguished by its robust coordination capabilities with transition metals, which enhances catalytic activity in asymmetric reactions. Its unique bisphosphine structure fosters strong chelation, promoting regioselectivity and stereoselectivity. The compound's conformational flexibility allows for tailored interactions with substrates, optimizing reaction conditions and improving yields of enantiomerically enriched products. | ||||||
(R)-(+)-2,2′-Bis(di-p-tolylphosphino)-1,1′-binaphthyl | 99646-28-3 | sc-250868 | 250 mg | $44.00 | ||
(R)-(+)-2,2'-Bis(di-p-tolylphosphino)-1,1'-binaphthyl serves as a chiral reagent characterized by its exceptional ability to stabilize transition states in asymmetric catalysis. The compound's rigid binaphthyl backbone provides a defined spatial arrangement, facilitating selective interactions with substrates. Its dual phosphine groups enhance metal coordination, leading to increased reaction rates and improved enantioselectivity, making it a powerful tool in the synthesis of chiral compounds. | ||||||
(R)-(+)-3-Chloro-1-phenyl-1-propanol | 100306-33-0 | sc-255490 | 1 g | $60.00 | ||
(R)-(+)-3-Chloro-1-phenyl-1-propanol is a chiral reagent notable for its unique stereochemical properties that influence reaction pathways in asymmetric synthesis. The presence of the chloro group introduces distinct steric and electronic effects, enhancing selectivity in nucleophilic attacks. Its ability to form stable intermediates allows for controlled reaction kinetics, making it an effective agent in generating enantiomerically enriched products through various catalytic processes. | ||||||